| Bioactivity | Yimitasvir (Emitasvir) diphosphate is an orally active hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor and can be used for research of chronic hepatitis C virus infection[1]. |
| Name | (1R,4S)-Yimitasvir diphosphate |
| CAS | 2734870-15-4 |
| Formula | C49H64N8O14P2 |
| Molar Mass | 1051.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huiying Rao, et al. Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis. J Clin Transl Hepatol. 2020 Sep 28;8(3):255-261. |
(1R,4S)-Yimitasvir diphosphate
CAS: 2734870-15-4 F: C49H64N8O14P2 W: 1051.03
Yimitasvir (Emitasvir) diphosphate is an orally active hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.